Now showing items 1-1 of 1

    • RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcoma. 

      Smith, HG; Jamal, K; Dayal, JH; Tenev, T; Kyula-Currie, J; Guppy, N; Gazinska, P; Roulstone, V; Liccardi, G; Davies, E; Roxanis, I; Melcher, AA; Hayes, AJ; Inman, GJ; Harrington, KJ; Meier, P (2020-06)
      Drugs that mobilise the immune system against cancer are dramatically improving care for many people. Dying cancer cells play an active role in inducing anti-tumour immunity but not every form of death can elicit an immune ...